These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25894268)

  • 1. [Progress in the development of insulin pumps and their advanced automatic functions].
    Prázný M
    Vnitr Lek; 2015 Apr; 61(4):355, 357, 359-60. PubMed ID: 25894268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Predictive Low Glucose Management System in Prevention of Clinically Significant Hypoglycemia in Type 1 Diabetes. A Preliminary Study Identifying the Most Common Events Leading Up to Hypoglycemia During Insulin Pump Therapy.
    Thomakos P; Mitrakou A; Kepaptsoglou O; Taraoune I; Barreto C; Zoupas CS
    Exp Clin Endocrinol Diabetes; 2021 May; 129(5):385-389. PubMed ID: 30986882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
    Pickup JC
    Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
    Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
    Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System.
    Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW
    Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.
    Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Hendrieckx C; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Speight J; Trawley S; Ward GM; Roy A; Jones TW; O'Neal DN
    Diabetes Technol Ther; 2016 Dec; 18(12):772-783. PubMed ID: 27835037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of the Predictive Hypoglycemia Minimizer System to the Algorithm Aggressiveness Factor.
    Finan DA; Dassau E; Breton MD; Patek SD; McCann TW; Kovatchev BP; Doyle FJ; Levy BL; Venugopalan R
    J Diabetes Sci Technol; 2015 Jun; 10(1):104-10. PubMed ID: 26134834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of real-life insulin pump with predictive low-glucose management use for 3 months: Analysis of the patients treated in a Japanese center.
    Tsunemi A; Sato J; Kurita M; Wakabayashi Y; Waseda N; Koshibu M; Shinohara M; Ozaki A; Nakamura H; Hirano N; Ikeda F; Satoh H; Watada H
    J Diabetes Investig; 2020 Nov; 11(6):1564-1569. PubMed ID: 32374513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin pumps with a sensor and threshold-suspend reduced nocturnal hypoglycemia in type 1 diabetes.
    McCoy R; Smith S
    Ann Intern Med; 2013 Sep; 159(6):JC7. PubMed ID: 24042390
    [No Abstract]   [Full Text] [Related]  

  • 10. Open-loop glucose control: Automatic IOB-based super-bolus feature for commercial insulin pumps.
    Rosales N; De Battista H; Vehí J; Garelli F
    Comput Methods Programs Biomed; 2018 Jun; 159():145-158. PubMed ID: 29650309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes.
    Abraham MB; Davey R; O'Grady MJ; Ly TT; Paramalingam N; Fournier PA; Roy A; Grosman B; Kurtz N; Fairchild JM; King BR; Ambler GR; Cameron F; Jones TW; Davis EA
    Diabetes Technol Ther; 2016 Sep; 18(9):543-50. PubMed ID: 27505305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.
    Agrawal P; Welsh JB; Kannard B; Askari S; Yang Q; Kaufman FR
    J Diabetes Sci Technol; 2011 Sep; 5(5):1137-41. PubMed ID: 22027306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial.
    Battelino T; Nimri R; Dovc K; Phillip M; Bratina N
    Diabetes Care; 2017 Jun; 40(6):764-770. PubMed ID: 28351897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
    Ly TT; Brnabic AJ; Eggleston A; Kolivos A; McBride ME; Schrover R; Jones TW
    Value Health; 2014 Jul; 17(5):561-9. PubMed ID: 25128049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
    Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
    J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin pump therapy in youth with type 1 diabetes: toward closed-loop systems.
    Tauschmann M; Hovorka R
    Expert Opin Drug Deliv; 2014 Jun; 11(6):943-55. PubMed ID: 24749563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Efficacy and Safety of Sensor Augmented Insulin Pump Therapy with Low-Glucose Suspend Feature in Patients with Type 1 Diabetes.
    Gómez AM; Marín Carrillo LF; Muñoz Velandia OM; Rondón Sepúlveda MA; Arévalo Correa CM; Mora Garzón E; Cuervo Diaz MC; Henao Carrillo DC
    Diabetes Technol Ther; 2017 Feb; 19(2):109-114. PubMed ID: 28001445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study.
    Guilhem I; Penet M; Paillard A; Carpentier M; Esvant A; Lefebvre MA; Poirier JY
    J Diabetes Sci Technol; 2017 Sep; 11(5):1007-1014. PubMed ID: 28677416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial.
    Kropff J; Del Favero S; Place J; Toffanin C; Visentin R; Monaro M; Messori M; Di Palma F; Lanzola G; Farret A; Boscari F; Galasso S; Magni P; Avogaro A; Keith-Hynes P; Kovatchev BP; Bruttomesso D; Cobelli C; DeVries JH; Renard E; Magni L;
    Lancet Diabetes Endocrinol; 2015 Dec; 3(12):939-47. PubMed ID: 26432775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging Technologies for Diabetes Care.
    Bailey TS; Walsh J; Stone JY
    Diabetes Technol Ther; 2018 Jun; 20(S2):S278-S284. PubMed ID: 29916738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.